These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38497684)

  • 1. Implication of acute tubular injury in minimal change nephrotic syndrome.
    Grainer H; DeVita MV; Leung TM; Bijol V; Rosenstock JL
    Clin Nephrol; 2024 May; 101(5):232-237. PubMed ID: 38497684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of acute kidney injury in patients with nephrotic syndrome and minimal change disease: a retrospective, cross-sectional study.
    Lin SP; Zhu FG; Meng JL; Sun XW; Cui J; Liang S; Yin Z; Sun XF; Cai GY
    Chin Med J (Engl); 2020 Nov; 134(2):206-211. PubMed ID: 33443939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique proximal tubular cell injury and the development of acute kidney injury in adult patients with minimal change nephrotic syndrome.
    Fujigaki Y; Tamura Y; Nagura M; Arai S; Ota T; Shibata S; Kondo F; Yamaguchi Y; Uchida S
    BMC Nephrol; 2017 Nov; 18(1):339. PubMed ID: 29179690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of acute kidney injury on coagulation in adult minimal change nephropathy.
    Huang MJ; Wei RB; Su TY; Wang Y; Li QP; Yang X; Lv XM; Chen XM
    Medicine (Baltimore); 2016 Nov; 95(46):e5366. PubMed ID: 27861367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute kidney injury complicating nephrotic syndrome of minimal change disease.
    Meyrier A; Niaudet P
    Kidney Int; 2018 Nov; 94(5):861-869. PubMed ID: 29980292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of acute kidney injury on the time to complete remission in adult minimal change nephrotic syndrome: a single-centre study.
    Komukai D; Hasegawa T; Kaneshima N; Takayasu M; Sato Y; Hirose M; Yoshimura A
    Nephrology (Carlton); 2016 Oct; 21(10):887-92. PubMed ID: 26603689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report.
    Leclerc S; Royal V; Lamarche C; Laurin LP
    Am J Kidney Dis; 2021 Oct; 78(4):607-610. PubMed ID: 34242687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of minimal change disease without nephrotic range proteinuria.
    Son HE; Yun G; Kwon EJ; Park S; Jeong JC; Kim S; Na KY; Paik JH; Chin HJ
    PLoS One; 2023; 18(8):e0289870. PubMed ID: 37590275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histopathological features of acute kidney injury in adult-onset minimal change nephrotic syndrome.
    Nishide K; Nakatani S; Mori K; Morioka F; Machiba Y; Uedono H; Tsuda A; Inaba M; Ishimura E; Emoto M
    Clin Exp Nephrol; 2021 Mar; 25(3):261-269. PubMed ID: 33247826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Kidney Injury and Nephrotic Syndrome in Guillain-Barre Syndrome: A Rare Clinical Scenario.
    Shamsudheen MP; Vijayan S; Kuchay A; Taduri G; Guditi S; Karthik R; Das U
    Saudi J Kidney Dis Transpl; 2021; 32(6):1804-1808. PubMed ID: 35946297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of acute kidney injury in patients with nephrotic syndrome.
    Tavares MB; Melo CVB; Fernandes PN; Almeida MDCC; Carneiro MFDSM; Santos RFS; Bahiense-Oliveira M; Martinelli R; Dos-Santos WL
    J Bras Nefrol; 2021; 43(1):20-27. PubMed ID: 32926065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors of acute kidney injury among childhood nephrotic syndrome: a prospective cohort study.
    Ghosh S; Akhtar S; Pradhan SK; Sarkar S; Dasgupta D; Parween R; Menon S; Sinha R
    Eur J Pediatr; 2023 May; 182(5):2443-2451. PubMed ID: 36920554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerulonephritis Histopathological Pattern Change.
    AlYousef A; AlSahow A; AlHelal B; Alqallaf A; Abdallah E; Abdellatif M; Nawar H; Elmahalawy R
    BMC Nephrol; 2020 May; 21(1):186. PubMed ID: 32423387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo minimal change disease associated with reversible post-transplant nephrotic syndrome. A report of five cases and review of literature.
    Zafarmand AA; Baranowska-Daca E; Ly PD; Tsao CC; Choi YJ; Suki WN; Truong LD
    Clin Transplant; 2002 Oct; 16(5):350-61. PubMed ID: 12225432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephrotic syndrome in children. Retrospective study at a concentration hospital].
    Amato D; Mendoza L; Gallardo Y; Santos D
    Bol Med Hosp Infant Mex; 1991 Jul; 48(7):484-9. PubMed ID: 1930717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases.
    Gupta RK; Bhargava R; Shaukat AA; Albert E; Leggat J
    BMC Nephrol; 2020 Aug; 21(1):326. PubMed ID: 32753052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
    Lebedev L; Sapojnikov M; Wechsler A; Varadi-Levi R; Zamir D; Tobar A; Levin-Iaina N; Fytlovich S; Yagil Y
    Am J Kidney Dis; 2021 Jul; 78(1):142-145. PubMed ID: 33839200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
    Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report.
    Kwon O; Kim Y; Paek JH; Park WY; Han S; Sin H; Jin K
    Medicine (Baltimore); 2022 Mar; 101(10):e28997. PubMed ID: 35451393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.